nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—SLC22A2—Vinblastine—germ cell cancer	0.14	0.308	CbGbCtD
Amantadine—SLC22A2—Cisplatin—germ cell cancer	0.128	0.282	CbGbCtD
Amantadine—ABCB1—Dactinomycin—germ cell cancer	0.0595	0.131	CbGbCtD
Amantadine—ABCB1—Vinblastine—germ cell cancer	0.0373	0.0819	CbGbCtD
Amantadine—ABCB1—Cisplatin—germ cell cancer	0.0342	0.0751	CbGbCtD
Amantadine—ABCB1—Etoposide—germ cell cancer	0.0336	0.0738	CbGbCtD
Amantadine—ABCB1—Methotrexate—germ cell cancer	0.0222	0.0487	CbGbCtD
Amantadine—GRIN1—telencephalic ventricle—germ cell cancer	0.0119	0.0481	CbGeAlD
Amantadine—GRIN2B—telencephalic ventricle—germ cell cancer	0.0113	0.0459	CbGeAlD
Amantadine—DDC—telencephalic ventricle—germ cell cancer	0.00926	0.0375	CbGeAlD
Amantadine—SLC22A2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00848	0.0804	CbGpPWpGaD
Amantadine—DDC—pineal body—germ cell cancer	0.00803	0.0325	CbGeAlD
Amantadine—SLC22A1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00791	0.075	CbGpPWpGaD
Amantadine—GRIN1—ganglion—germ cell cancer	0.0074	0.0299	CbGeAlD
Amantadine—GRIN2B—ganglion—germ cell cancer	0.00706	0.0286	CbGeAlD
Amantadine—GRIN2A—ganglion—germ cell cancer	0.00617	0.025	CbGeAlD
Amantadine—SLC22A2—Organic cation transport—SLC22A3—germ cell cancer	0.00582	0.0552	CbGpPWpGaD
Amantadine—DDC—ganglion—germ cell cancer	0.00576	0.0233	CbGeAlD
Amantadine—SLC22A1—Organic cation transport—SLC22A3—germ cell cancer	0.00543	0.0515	CbGpPWpGaD
Amantadine—SLC22A2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00487	0.0462	CbGpPWpGaD
Amantadine—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00463	0.0439	CbGpPWpGaD
Amantadine—SLC22A1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00454	0.0431	CbGpPWpGaD
Amantadine—GRIN3B—testis—germ cell cancer	0.00431	0.0175	CbGeAlD
Amantadine—DRD2—telencephalic ventricle—germ cell cancer	0.00402	0.0163	CbGeAlD
Amantadine—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00395	0.0375	CbGpPWpGaD
Amantadine—GRIN2C—brainstem—germ cell cancer	0.00388	0.0157	CbGeAlD
Amantadine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00368	0.0349	CbGpPWpGaD
Amantadine—GRIN2D—brainstem—germ cell cancer	0.00361	0.0146	CbGeAlD
Amantadine—DDC—Dopaminergic Neurogenesis—SOX2—germ cell cancer	0.0036	0.0341	CbGpPWpGaD
Amantadine—GRIN2C—telencephalon—germ cell cancer	0.00344	0.0139	CbGeAlD
Amantadine—SLC22A1—ganglion—germ cell cancer	0.00335	0.0136	CbGeAlD
Amantadine—GRIN1—brainstem—germ cell cancer	0.00322	0.013	CbGeAlD
Amantadine—GRIN2D—telencephalon—germ cell cancer	0.0032	0.013	CbGeAlD
Amantadine—GRIN2B—brainstem—germ cell cancer	0.00307	0.0124	CbGeAlD
Amantadine—GRIN3A—telencephalon—germ cell cancer	0.00301	0.0122	CbGeAlD
Amantadine—MAOB—ganglion—germ cell cancer	0.00297	0.012	CbGeAlD
Amantadine—GRIN1—telencephalon—germ cell cancer	0.00285	0.0116	CbGeAlD
Amantadine—DDC—embryo—germ cell cancer	0.00273	0.0111	CbGeAlD
Amantadine—GRIN2B—telencephalon—germ cell cancer	0.00272	0.011	CbGeAlD
Amantadine—GRIN2C—medulla oblongata—germ cell cancer	0.00271	0.011	CbGeAlD
Amantadine—GRIN2A—brainstem—germ cell cancer	0.00268	0.0109	CbGeAlD
Amantadine—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00266	0.0252	CbGpPWpGaD
Amantadine—GRIN2D—medulla oblongata—germ cell cancer	0.00252	0.0102	CbGeAlD
Amantadine—DDC—brainstem—germ cell cancer	0.00251	0.0101	CbGeAlD
Amantadine—DRD2—ganglion—germ cell cancer	0.0025	0.0101	CbGeAlD
Amantadine—GRIN2A—telencephalon—germ cell cancer	0.00238	0.00963	CbGeAlD
Amantadine—SLC22A2—trigeminal ganglion—germ cell cancer	0.00233	0.00944	CbGeAlD
Amantadine—GRIN2D—spinal cord—germ cell cancer	0.00224	0.00908	CbGeAlD
Amantadine—DDC—telencephalon—germ cell cancer	0.00222	0.009	CbGeAlD
Amantadine—GRIN2C—head—germ cell cancer	0.00214	0.00868	CbGeAlD
Amantadine—GRIN2C—testis—germ cell cancer	0.00207	0.00839	CbGeAlD
Amantadine—GRIN1—midbrain—germ cell cancer	0.00205	0.00829	CbGeAlD
Amantadine—GRIN1—spinal cord—germ cell cancer	0.002	0.00809	CbGeAlD
Amantadine—GRIN2D—head—germ cell cancer	0.00199	0.00807	CbGeAlD
Amantadine—GRIN2D—testis—germ cell cancer	0.00193	0.0078	CbGeAlD
Amantadine—GRIN2C—cerebellum—germ cell cancer	0.00191	0.00774	CbGeAlD
Amantadine—GRIN2B—spinal cord—germ cell cancer	0.00191	0.00772	CbGeAlD
Amantadine—GRIN3A—head—germ cell cancer	0.00187	0.00759	CbGeAlD
Amantadine—GRIN2A—medulla oblongata—germ cell cancer	0.00187	0.00757	CbGeAlD
Amantadine—GRIN3A—testis—germ cell cancer	0.00181	0.00733	CbGeAlD
Amantadine—DDC—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.0018	0.0171	CbGpPWpGaD
Amantadine—GRIN1—endocrine gland—germ cell cancer	0.0018	0.00729	CbGeAlD
Amantadine—GRIN2D—cerebellum—germ cell cancer	0.00178	0.0072	CbGeAlD
Amantadine—GRIN1—head—germ cell cancer	0.00178	0.00719	CbGeAlD
Amantadine—DDC—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.00173	0.0164	CbGpPWpGaD
Amantadine—GRIN2A—adrenal gland—germ cell cancer	0.00173	0.00701	CbGeAlD
Amantadine—GRIN2B—endocrine gland—germ cell cancer	0.00172	0.00695	CbGeAlD
Amantadine—GRIN2A—midbrain—germ cell cancer	0.00171	0.00692	CbGeAlD
Amantadine—GRIN2B—head—germ cell cancer	0.0017	0.00686	CbGeAlD
Amantadine—GRIN2A—spinal cord—germ cell cancer	0.00167	0.00675	CbGeAlD
Amantadine—DDC—adrenal gland—germ cell cancer	0.00162	0.00655	CbGeAlD
Amantadine—DDC—midbrain—germ cell cancer	0.0016	0.00646	CbGeAlD
Amantadine—GRIN1—cerebellum—germ cell cancer	0.00159	0.00642	CbGeAlD
Amantadine—GRIN1—Mecp2 and Associated Rett Syndrome—FGF4—germ cell cancer	0.00156	0.0148	CbGpPWpGaD
Amantadine—GRIN2C—brain—germ cell cancer	0.00155	0.00629	CbGeAlD
Amantadine—GRIN1—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.00155	0.0147	CbGpPWpGaD
Amantadine—SIGMAR1—trigeminal ganglion—germ cell cancer	0.00152	0.00616	CbGeAlD
Amantadine—GRIN2B—cerebellum—germ cell cancer	0.00151	0.00612	CbGeAlD
Amantadine—GRIN2A—endocrine gland—germ cell cancer	0.0015	0.00608	CbGeAlD
Amantadine—GRIN1—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.00149	0.0141	CbGpPWpGaD
Amantadine—GRIN2A—head—germ cell cancer	0.00148	0.006	CbGeAlD
Amantadine—MAOB—trigeminal ganglion—germ cell cancer	0.00146	0.00589	CbGeAlD
Amantadine—GRIN2D—brain—germ cell cancer	0.00145	0.00585	CbGeAlD
Amantadine—GRIN2A—testis—germ cell cancer	0.00143	0.00579	CbGeAlD
Amantadine—Amnesia—Ifosfamide—germ cell cancer	0.00142	0.00737	CcSEcCtD
Amantadine—MAOB—embryo—germ cell cancer	0.00141	0.00569	CbGeAlD
Amantadine—DDC—endocrine gland—germ cell cancer	0.0014	0.00568	CbGeAlD
Amantadine—DDC—head—germ cell cancer	0.00138	0.0056	CbGeAlD
Amantadine—Cardiac failure—Ifosfamide—germ cell cancer	0.00137	0.0071	CcSEcCtD
Amantadine—GRIN3A—brain—germ cell cancer	0.00136	0.0055	CbGeAlD
Amantadine—Liver function test abnormal—Dactinomycin—germ cell cancer	0.00134	0.00698	CcSEcCtD
Amantadine—DDC—testis—germ cell cancer	0.00134	0.00541	CbGeAlD
Amantadine—Osteoarthritis—Ifosfamide—germ cell cancer	0.00133	0.00693	CcSEcCtD
Amantadine—Agranulocytosis—Vinblastine—germ cell cancer	0.00133	0.0069	CcSEcCtD
Amantadine—GRIN2A—cerebellum—germ cell cancer	0.00132	0.00535	CbGeAlD
Amantadine—SIGMAR1—eye—germ cell cancer	0.00131	0.0053	CbGeAlD
Amantadine—Psychotic disorder—Ifosfamide—germ cell cancer	0.0013	0.00676	CcSEcCtD
Amantadine—SLC22A1—telencephalon—germ cell cancer	0.00129	0.00523	CbGeAlD
Amantadine—MAOB—brainstem—germ cell cancer	0.00129	0.00522	CbGeAlD
Amantadine—GRIN1—brain—germ cell cancer	0.00129	0.00521	CbGeAlD
Amantadine—Cardiac arrest—Ifosfamide—germ cell cancer	0.00127	0.00659	CcSEcCtD
Amantadine—Urinary retention—Ifosfamide—germ cell cancer	0.00127	0.00659	CcSEcCtD
Amantadine—Cardiac failure congestive—Cisplatin—germ cell cancer	0.00127	0.00658	CcSEcCtD
Amantadine—Dysphagia—Dactinomycin—germ cell cancer	0.00126	0.00653	CcSEcCtD
Amantadine—Paralysis—Methotrexate—germ cell cancer	0.00125	0.0065	CcSEcCtD
Amantadine—Renal failure acute—Cisplatin—germ cell cancer	0.00124	0.00647	CcSEcCtD
Amantadine—GRIN2B—brain—germ cell cancer	0.00123	0.00497	CbGeAlD
Amantadine—Amnesia—Cisplatin—germ cell cancer	0.00122	0.00636	CcSEcCtD
Amantadine—SIGMAR1—telencephalon—germ cell cancer	0.00119	0.00484	CbGeAlD
Amantadine—GRIN2C—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—germ cell cancer	0.00119	0.0113	CbGpPWpGaD
Amantadine—Neutropenia—Dactinomycin—germ cell cancer	0.00118	0.00611	CcSEcCtD
Amantadine—Stupor—Methotrexate—germ cell cancer	0.00116	0.00605	CcSEcCtD
Amantadine—Cardiac failure congestive—Etoposide—germ cell cancer	0.00116	0.00603	CcSEcCtD
Amantadine—MAOB—telencephalon—germ cell cancer	0.00114	0.00463	CbGeAlD
Amantadine—SIGMAR1—decidua—germ cell cancer	0.00113	0.00458	CbGeAlD
Amantadine—Alopecia—Vinblastine—germ cell cancer	0.00113	0.00587	CcSEcCtD
Amantadine—GRIN2D—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—germ cell cancer	0.00111	0.0105	CbGpPWpGaD
Amantadine—Irritability—Cisplatin—germ cell cancer	0.0011	0.0057	CcSEcCtD
Amantadine—DRD2—brainstem—germ cell cancer	0.00109	0.0044	CbGeAlD
Amantadine—MAOB—decidua—germ cell cancer	0.00108	0.00439	CbGeAlD
Amantadine—Cardiac failure—Etoposide—germ cell cancer	0.00108	0.0056	CcSEcCtD
Amantadine—GRIN2A—brain—germ cell cancer	0.00107	0.00435	CbGeAlD
Amantadine—DRD2—eye—germ cell cancer	0.00106	0.00429	CbGeAlD
Amantadine—Orthostatic hypotension—Cisplatin—germ cell cancer	0.00105	0.00545	CcSEcCtD
Amantadine—DRD2—retina—germ cell cancer	0.00105	0.00425	CbGeAlD
Amantadine—Agranulocytosis—Dactinomycin—germ cell cancer	0.00105	0.00544	CcSEcCtD
Amantadine—DDC—brain—germ cell cancer	0.001	0.00406	CbGeAlD
Amantadine—Cardiac arrest—Etoposide—germ cell cancer	0.001	0.0052	CcSEcCtD
Amantadine—Leukopenia—Vinblastine—germ cell cancer	0.000995	0.00517	CcSEcCtD
Amantadine—SIGMAR1—uterus—germ cell cancer	0.000991	0.00401	CbGeAlD
Amantadine—SIGMAR1—pituitary gland—germ cell cancer	0.000973	0.00394	CbGeAlD
Amantadine—DDC—lymph node—germ cell cancer	0.00097	0.00392	CbGeAlD
Amantadine—Sweating increased—Cisplatin—germ cell cancer	0.000967	0.00503	CcSEcCtD
Amantadine—DRD2—telencephalon—germ cell cancer	0.000965	0.00391	CbGeAlD
Amantadine—Convulsion—Vinblastine—germ cell cancer	0.000963	0.00501	CcSEcCtD
Amantadine—DDC—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000962	0.00912	CbGpPWpGaD
Amantadine—Hypertension—Vinblastine—germ cell cancer	0.00096	0.00499	CcSEcCtD
Amantadine—Agranulocytosis—Ifosfamide—germ cell cancer	0.000959	0.00498	CcSEcCtD
Amantadine—Alopecia—Bleomycin—germ cell cancer	0.000953	0.00495	CcSEcCtD
Amantadine—MAOB—uterus—germ cell cancer	0.000948	0.00384	CbGeAlD
Amantadine—SIGMAR1—medulla oblongata—germ cell cancer	0.000939	0.0038	CbGeAlD
Amantadine—MAOB—pituitary gland—germ cell cancer	0.000931	0.00377	CbGeAlD
Amantadine—Dysarthria—Methotrexate—germ cell cancer	0.000918	0.00477	CcSEcCtD
Amantadine—Hallucination—Ifosfamide—germ cell cancer	0.000917	0.00477	CcSEcCtD
Amantadine—Urinary tract disorder—Ifosfamide—germ cell cancer	0.000911	0.00473	CcSEcCtD
Amantadine—Dysphagia—Etoposide—germ cell cancer	0.00091	0.00473	CcSEcCtD
Amantadine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—germ cell cancer	0.000908	0.00861	CbGpPWpGaD
Amantadine—Urethral disorder—Ifosfamide—germ cell cancer	0.000904	0.0047	CcSEcCtD
Amantadine—MAOB—medulla oblongata—germ cell cancer	0.000899	0.00364	CbGeAlD
Amantadine—Alopecia—Dactinomycin—germ cell cancer	0.000889	0.00462	CcSEcCtD
Amantadine—Visual impairment—Ifosfamide—germ cell cancer	0.000889	0.00462	CcSEcCtD
Amantadine—Sweating increased—Etoposide—germ cell cancer	0.000886	0.00461	CcSEcCtD
Amantadine—SIGMAR1—adrenal gland—germ cell cancer	0.000869	0.00352	CbGeAlD
Amantadine—Anorexia—Vinblastine—germ cell cancer	0.000865	0.0045	CcSEcCtD
Amantadine—Eye disorder—Ifosfamide—germ cell cancer	0.000862	0.00448	CcSEcCtD
Amantadine—ABCB1—blood vessel—germ cell cancer	0.00086	0.00348	CbGeAlD
Amantadine—SIGMAR1—midbrain—germ cell cancer	0.000858	0.00347	CbGeAlD
Amantadine—Cardiac disorder—Ifosfamide—germ cell cancer	0.000856	0.00445	CcSEcCtD
Amantadine—GRIN1—BDNF signaling pathway—ALPL—germ cell cancer	0.000854	0.00809	CbGpPWpGaD
Amantadine—Neutropenia—Etoposide—germ cell cancer	0.000851	0.00442	CcSEcCtD
Amantadine—GRIN2C—CREB phosphorylation through the activation of Ras—HRAS—germ cell cancer	0.000848	0.00804	CbGpPWpGaD
Amantadine—SIGMAR1—bone marrow—germ cell cancer	0.000841	0.0034	CbGeAlD
Amantadine—Leukopenia—Bleomycin—germ cell cancer	0.000841	0.00437	CcSEcCtD
Amantadine—Depressed level of consciousness—Methotrexate—germ cell cancer	0.000839	0.00436	CcSEcCtD
Amantadine—SIGMAR1—spinal cord—germ cell cancer	0.000837	0.00339	CbGeAlD
Amantadine—Angiopathy—Ifosfamide—germ cell cancer	0.000837	0.00435	CcSEcCtD
Amantadine—GRIN2B—BDNF signaling pathway—ALPL—germ cell cancer	0.000832	0.00789	CbGpPWpGaD
Amantadine—MAOB—adrenal gland—germ cell cancer	0.000832	0.00337	CbGeAlD
Amantadine—Mediastinal disorder—Ifosfamide—germ cell cancer	0.000831	0.00432	CcSEcCtD
Amantadine—GRIN1—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000827	0.00784	CbGpPWpGaD
Amantadine—Arrhythmia—Ifosfamide—germ cell cancer	0.000824	0.00428	CcSEcCtD
Amantadine—MAOB—midbrain—germ cell cancer	0.000821	0.00332	CbGeAlD
Amantadine—SLC22A1—endocrine gland—germ cell cancer	0.000816	0.0033	CbGeAlD
Amantadine—Paraesthesia—Vinblastine—germ cell cancer	0.000815	0.00423	CcSEcCtD
Amantadine—Alopecia—Ifosfamide—germ cell cancer	0.000815	0.00423	CcSEcCtD
Amantadine—SIGMAR1—female gonad—germ cell cancer	0.00081	0.00328	CbGeAlD
Amantadine—Mental disorder—Ifosfamide—germ cell cancer	0.000808	0.0042	CcSEcCtD
Amantadine—SLC22A1—head—germ cell cancer	0.000805	0.00326	CbGeAlD
Amantadine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000803	0.00762	CbGpPWpGaD
Amantadine—Malnutrition—Ifosfamide—germ cell cancer	0.000803	0.00417	CcSEcCtD
Amantadine—MAOB—spinal cord—germ cell cancer	0.000801	0.00324	CbGeAlD
Amantadine—Coma—Methotrexate—germ cell cancer	0.000794	0.00412	CcSEcCtD
Amantadine—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—germ cell cancer	0.000792	0.00751	CbGpPWpGaD
Amantadine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000791	0.0075	CbGpPWpGaD
Amantadine—Decreased appetite—Vinblastine—germ cell cancer	0.000789	0.0041	CcSEcCtD
Amantadine—GRIN2D—CREB phosphorylation through the activation of Ras—HRAS—germ cell cancer	0.000789	0.00748	CbGpPWpGaD
Amantadine—DRD2—pituitary gland—germ cell cancer	0.000786	0.00318	CbGeAlD
Amantadine—Urinary tract disorder—Cisplatin—germ cell cancer	0.000785	0.00408	CcSEcCtD
Amantadine—Leukopenia—Dactinomycin—germ cell cancer	0.000784	0.00407	CcSEcCtD
Amantadine—Urethral disorder—Cisplatin—germ cell cancer	0.000779	0.00405	CcSEcCtD
Amantadine—Constipation—Vinblastine—germ cell cancer	0.000776	0.00403	CcSEcCtD
Amantadine—MAOB—female gonad—germ cell cancer	0.000776	0.00314	CbGeAlD
Amantadine—Pulmonary oedema—Methotrexate—germ cell cancer	0.000773	0.00402	CcSEcCtD
Amantadine—Confusional state—Bleomycin—germ cell cancer	0.000773	0.00402	CcSEcCtD
Amantadine—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—germ cell cancer	0.000772	0.00732	CbGpPWpGaD
Amantadine—Oedema—Bleomycin—germ cell cancer	0.000767	0.00398	CcSEcCtD
Amantadine—Anaphylactic shock—Bleomycin—germ cell cancer	0.000767	0.00398	CcSEcCtD
Amantadine—Visual impairment—Cisplatin—germ cell cancer	0.000766	0.00398	CcSEcCtD
Amantadine—Agranulocytosis—Etoposide—germ cell cancer	0.000757	0.00393	CcSEcCtD
Amantadine—Vision blurred—Ifosfamide—germ cell cancer	0.000756	0.00393	CcSEcCtD
Amantadine—GRIN1—Developmental Biology—TDGF1—germ cell cancer	0.000755	0.00716	CbGpPWpGaD
Amantadine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000749	0.0071	CbGpPWpGaD
Amantadine—Feeling abnormal—Vinblastine—germ cell cancer	0.000748	0.00389	CcSEcCtD
Amantadine—Eye disorder—Cisplatin—germ cell cancer	0.000743	0.00386	CcSEcCtD
Amantadine—Cardiac disorder—Cisplatin—germ cell cancer	0.000738	0.00383	CcSEcCtD
Amantadine—Agitation—Ifosfamide—germ cell cancer	0.000738	0.00383	CcSEcCtD
Amantadine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000737	0.00699	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—TDGF1—germ cell cancer	0.000736	0.00698	CbGpPWpGaD
Amantadine—Anorexia—Bleomycin—germ cell cancer	0.000731	0.0038	CcSEcCtD
Amantadine—MAOB—endocrine gland—germ cell cancer	0.000722	0.00292	CbGeAlD
Amantadine—Urinary tract disorder—Etoposide—germ cell cancer	0.000719	0.00374	CcSEcCtD
Amantadine—SIGMAR1—testis—germ cell cancer	0.000719	0.00291	CbGeAlD
Amantadine—Leukopenia—Ifosfamide—germ cell cancer	0.000718	0.00373	CcSEcCtD
Amantadine—Photosensitivity—Methotrexate—germ cell cancer	0.000718	0.00373	CcSEcCtD
Amantadine—Mediastinal disorder—Cisplatin—germ cell cancer	0.000716	0.00372	CcSEcCtD
Amantadine—Hypotension—Bleomycin—germ cell cancer	0.000716	0.00372	CcSEcCtD
Amantadine—Oedema—Dactinomycin—germ cell cancer	0.000715	0.00371	CcSEcCtD
Amantadine—Urethral disorder—Etoposide—germ cell cancer	0.000714	0.00371	CcSEcCtD
Amantadine—MAOB—head—germ cell cancer	0.000712	0.00288	CbGeAlD
Amantadine—Arrhythmia—Cisplatin—germ cell cancer	0.00071	0.00369	CcSEcCtD
Amantadine—Palpitations—Ifosfamide—germ cell cancer	0.000709	0.00369	CcSEcCtD
Amantadine—Alopecia—Cisplatin—germ cell cancer	0.000702	0.00365	CcSEcCtD
Amantadine—GRIN2C—Post NMDA receptor activation events—HRAS—germ cell cancer	0.000698	0.00662	CbGpPWpGaD
Amantadine—Convulsion—Ifosfamide—germ cell cancer	0.000695	0.00361	CcSEcCtD
Amantadine—DRD2—midbrain—germ cell cancer	0.000693	0.00281	CbGeAlD
Amantadine—Hypertension—Ifosfamide—germ cell cancer	0.000693	0.0036	CcSEcCtD
Amantadine—Malnutrition—Cisplatin—germ cell cancer	0.000692	0.0036	CcSEcCtD
Amantadine—Paraesthesia—Bleomycin—germ cell cancer	0.000688	0.00358	CcSEcCtD
Amantadine—MAOB—testis—germ cell cancer	0.000688	0.00278	CbGeAlD
Amantadine—Dyspnoea—Bleomycin—germ cell cancer	0.000683	0.00355	CcSEcCtD
Amantadine—Renal failure acute—Methotrexate—germ cell cancer	0.000683	0.00355	CcSEcCtD
Amantadine—Anorexia—Dactinomycin—germ cell cancer	0.000681	0.00354	CcSEcCtD
Amantadine—Eye disorder—Etoposide—germ cell cancer	0.000681	0.00354	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000679	0.00353	CcSEcCtD
Amantadine—Cardiac disorder—Etoposide—germ cell cancer	0.000676	0.00351	CcSEcCtD
Amantadine—Hypersensitivity—Vinblastine—germ cell cancer	0.000669	0.00347	CcSEcCtD
Amantadine—Decreased appetite—Bleomycin—germ cell cancer	0.000666	0.00346	CcSEcCtD
Amantadine—Visual disturbance—Methotrexate—germ cell cancer	0.000665	0.00346	CcSEcCtD
Amantadine—SIGMAR1—cerebellum—germ cell cancer	0.000664	0.00269	CbGeAlD
Amantadine—Angiopathy—Etoposide—germ cell cancer	0.000661	0.00343	CcSEcCtD
Amantadine—Confusional state—Ifosfamide—germ cell cancer	0.000661	0.00343	CcSEcCtD
Amantadine—Mediastinal disorder—Etoposide—germ cell cancer	0.000656	0.00341	CcSEcCtD
Amantadine—Oedema—Ifosfamide—germ cell cancer	0.000655	0.0034	CcSEcCtD
Amantadine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000655	0.0034	CcSEcCtD
Amantadine—Vision blurred—Cisplatin—germ cell cancer	0.000652	0.00339	CcSEcCtD
Amantadine—Asthenia—Vinblastine—germ cell cancer	0.000651	0.00338	CcSEcCtD
Amantadine—GRIN2D—Post NMDA receptor activation events—HRAS—germ cell cancer	0.000649	0.00615	CbGpPWpGaD
Amantadine—Tremor—Cisplatin—germ cell cancer	0.000648	0.00337	CcSEcCtD
Amantadine—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—germ cell cancer	0.000648	0.00614	CbGpPWpGaD
Amantadine—Alopecia—Etoposide—germ cell cancer	0.000644	0.00334	CcSEcCtD
Amantadine—Lethargy—Methotrexate—germ cell cancer	0.000643	0.00334	CcSEcCtD
Amantadine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—germ cell cancer	0.000643	0.0061	CbGpPWpGaD
Amantadine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000642	0.00334	CcSEcCtD
Amantadine—GRIN1—Developmental Biology—SALL4—germ cell cancer	0.000642	0.00609	CbGpPWpGaD
Amantadine—Skin disorder—Ifosfamide—germ cell cancer	0.000636	0.00331	CcSEcCtD
Amantadine—MAOB—cerebellum—germ cell cancer	0.000636	0.00257	CbGeAlD
Amantadine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000633	0.00329	CcSEcCtD
Amantadine—Feeling abnormal—Bleomycin—germ cell cancer	0.000632	0.00328	CcSEcCtD
Amantadine—Osteoarthritis—Methotrexate—germ cell cancer	0.000631	0.00328	CcSEcCtD
Amantadine—GRIN2B—Developmental Biology—SALL4—germ cell cancer	0.000626	0.00594	CbGpPWpGaD
Amantadine—Anorexia—Ifosfamide—germ cell cancer	0.000624	0.00324	CcSEcCtD
Amantadine—Decreased appetite—Dactinomycin—germ cell cancer	0.000621	0.00323	CcSEcCtD
Amantadine—Diarrhoea—Vinblastine—germ cell cancer	0.000621	0.00323	CcSEcCtD
Amantadine—Leukopenia—Cisplatin—germ cell cancer	0.000619	0.00322	CcSEcCtD
Amantadine—Fatigue—Dactinomycin—germ cell cancer	0.000616	0.0032	CcSEcCtD
Amantadine—GRIN1—Developmental Biology—NANOG—germ cell cancer	0.000616	0.00584	CbGpPWpGaD
Amantadine—Hypotension—Ifosfamide—germ cell cancer	0.000612	0.00318	CcSEcCtD
Amantadine—DRD2—endocrine gland—germ cell cancer	0.000609	0.00246	CbGeAlD
Amantadine—Body temperature increased—Bleomycin—germ cell cancer	0.000606	0.00315	CcSEcCtD
Amantadine—Irritability—Methotrexate—germ cell cancer	0.000602	0.00313	CcSEcCtD
Amantadine—DRD2—head—germ cell cancer	0.000601	0.00243	CbGeAlD
Amantadine—GRIN2B—Developmental Biology—NANOG—germ cell cancer	0.0006	0.00569	CbGpPWpGaD
Amantadine—Dizziness—Vinblastine—germ cell cancer	0.0006	0.00312	CcSEcCtD
Amantadine—Convulsion—Cisplatin—germ cell cancer	0.0006	0.00312	CcSEcCtD
Amantadine—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—germ cell cancer	0.000598	0.00567	CbGpPWpGaD
Amantadine—Ataxia—Methotrexate—germ cell cancer	0.000593	0.00308	CcSEcCtD
Amantadine—GRIN1—Developmental Biology—POU5F1—germ cell cancer	0.000593	0.00562	CbGpPWpGaD
Amantadine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000589	0.00306	CcSEcCtD
Amantadine—Paraesthesia—Ifosfamide—germ cell cancer	0.000588	0.00306	CcSEcCtD
Amantadine—Anxiety—Cisplatin—germ cell cancer	0.000587	0.00305	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000585	0.00304	CcSEcCtD
Amantadine—Dyspnoea—Ifosfamide—germ cell cancer	0.000584	0.00303	CcSEcCtD
Amantadine—SLC22A1—brain—germ cell cancer	0.000584	0.00236	CbGeAlD
Amantadine—Somnolence—Ifosfamide—germ cell cancer	0.000582	0.00303	CcSEcCtD
Amantadine—Liver function test abnormal—Methotrexate—germ cell cancer	0.000582	0.00302	CcSEcCtD
Amantadine—DRD2—testis—germ cell cancer	0.000581	0.00235	CbGeAlD
Amantadine—GRIN2B—Developmental Biology—POU5F1—germ cell cancer	0.000578	0.00548	CbGpPWpGaD
Amantadine—Vomiting—Vinblastine—germ cell cancer	0.000577	0.003	CcSEcCtD
Amantadine—Decreased appetite—Ifosfamide—germ cell cancer	0.000569	0.00296	CcSEcCtD
Amantadine—Headache—Vinblastine—germ cell cancer	0.000569	0.00295	CcSEcCtD
Amantadine—Leukopenia—Etoposide—germ cell cancer	0.000567	0.00295	CcSEcCtD
Amantadine—DDC—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000567	0.00538	CbGpPWpGaD
Amantadine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000566	0.00294	CcSEcCtD
Amantadine—Body temperature increased—Dactinomycin—germ cell cancer	0.000565	0.00294	CcSEcCtD
Amantadine—GRIN1—CREB phosphorylation through the activation of Ras—HRAS—germ cell cancer	0.000565	0.00536	CbGpPWpGaD
Amantadine—Fatigue—Ifosfamide—germ cell cancer	0.000565	0.00293	CcSEcCtD
Amantadine—Anaphylactic shock—Cisplatin—germ cell cancer	0.000565	0.00293	CcSEcCtD
Amantadine—Oedema—Cisplatin—germ cell cancer	0.000565	0.00293	CcSEcCtD
Amantadine—Hypersensitivity—Bleomycin—germ cell cancer	0.000565	0.00293	CcSEcCtD
Amantadine—Constipation—Ifosfamide—germ cell cancer	0.00056	0.00291	CcSEcCtD
Amantadine—Nervous system disorder—Cisplatin—germ cell cancer	0.000554	0.00288	CcSEcCtD
Amantadine—Tachycardia—Cisplatin—germ cell cancer	0.000551	0.00286	CcSEcCtD
Amantadine—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—germ cell cancer	0.000551	0.00522	CbGpPWpGaD
Amantadine—Asthenia—Bleomycin—germ cell cancer	0.00055	0.00286	CcSEcCtD
Amantadine—Convulsion—Etoposide—germ cell cancer	0.000549	0.00285	CcSEcCtD
Amantadine—Skin disorder—Cisplatin—germ cell cancer	0.000549	0.00285	CcSEcCtD
Amantadine—Hypertension—Etoposide—germ cell cancer	0.000547	0.00284	CcSEcCtD
Amantadine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000546	0.00284	CcSEcCtD
Amantadine—Pruritus—Bleomycin—germ cell cancer	0.000542	0.00282	CcSEcCtD
Amantadine—Feeling abnormal—Ifosfamide—germ cell cancer	0.00054	0.00281	CcSEcCtD
Amantadine—SIGMAR1—brain—germ cell cancer	0.000539	0.00218	CbGeAlD
Amantadine—Nausea—Vinblastine—germ cell cancer	0.000539	0.0028	CcSEcCtD
Amantadine—Anorexia—Cisplatin—germ cell cancer	0.000538	0.0028	CcSEcCtD
Amantadine—DRD2—cerebellum—germ cell cancer	0.000536	0.00217	CbGeAlD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000536	0.00279	CcSEcCtD
Amantadine—GRIN2A—Post NMDA receptor activation events—HRAS—germ cell cancer	0.000533	0.00505	CbGpPWpGaD
Amantadine—ABCB1—trigeminal ganglion—germ cell cancer	0.000531	0.00215	CbGeAlD
Amantadine—Hypotension—Cisplatin—germ cell cancer	0.000528	0.00274	CcSEcCtD
Amantadine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000527	0.00274	CcSEcCtD
Amantadine—Confusional state—Etoposide—germ cell cancer	0.000522	0.00271	CcSEcCtD
Amantadine—SIGMAR1—lymph node—germ cell cancer	0.000521	0.00211	CbGeAlD
Amantadine—Body temperature increased—Ifosfamide—germ cell cancer	0.000518	0.00269	CcSEcCtD
Amantadine—Anaphylactic shock—Etoposide—germ cell cancer	0.000517	0.00269	CcSEcCtD
Amantadine—MAOB—brain—germ cell cancer	0.000516	0.00209	CbGeAlD
Amantadine—ABCB1—embryo—germ cell cancer	0.000513	0.00208	CbGeAlD
Amantadine—Asthenia—Dactinomycin—germ cell cancer	0.000513	0.00267	CcSEcCtD
Amantadine—Neutropenia—Methotrexate—germ cell cancer	0.00051	0.00265	CcSEcCtD
Amantadine—Paraesthesia—Cisplatin—germ cell cancer	0.000507	0.00264	CcSEcCtD
Amantadine—Tachycardia—Etoposide—germ cell cancer	0.000505	0.00262	CcSEcCtD
Amantadine—Dyspnoea—Cisplatin—germ cell cancer	0.000503	0.00262	CcSEcCtD
Amantadine—Skin disorder—Etoposide—germ cell cancer	0.000503	0.00261	CcSEcCtD
Amantadine—Hyperhidrosis—Etoposide—germ cell cancer	0.0005	0.0026	CcSEcCtD
Amantadine—MAOB—lymph node—germ cell cancer	0.000499	0.00202	CbGeAlD
Amantadine—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000497	0.00258	CcSEcCtD
Amantadine—Anorexia—Etoposide—germ cell cancer	0.000493	0.00256	CcSEcCtD
Amantadine—Decreased appetite—Cisplatin—germ cell cancer	0.000491	0.00255	CcSEcCtD
Amantadine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—germ cell cancer	0.000491	0.00465	CbGpPWpGaD
Amantadine—Diarrhoea—Dactinomycin—germ cell cancer	0.000489	0.00254	CcSEcCtD
Amantadine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000488	0.00253	CcSEcCtD
Amantadine—Vomiting—Bleomycin—germ cell cancer	0.000487	0.00253	CcSEcCtD
Amantadine—GRIN1—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000487	0.00462	CbGpPWpGaD
Amantadine—Hypotension—Etoposide—germ cell cancer	0.000483	0.00251	CcSEcCtD
Amantadine—Rash—Bleomycin—germ cell cancer	0.000483	0.00251	CcSEcCtD
Amantadine—Dermatitis—Bleomycin—germ cell cancer	0.000483	0.00251	CcSEcCtD
Amantadine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000483	0.00251	CcSEcCtD
Amantadine—Asthenia—Ifosfamide—germ cell cancer	0.00047	0.00244	CcSEcCtD
Amantadine—GRIN1—Developmental Biology—KLF4—germ cell cancer	0.000467	0.00442	CbGpPWpGaD
Amantadine—Feeling abnormal—Cisplatin—germ cell cancer	0.000465	0.00242	CcSEcCtD
Amantadine—GRIN1—Post NMDA receptor activation events—HRAS—germ cell cancer	0.000465	0.00441	CbGpPWpGaD
Amantadine—Paraesthesia—Etoposide—germ cell cancer	0.000465	0.00241	CcSEcCtD
Amantadine—Pruritus—Ifosfamide—germ cell cancer	0.000463	0.00241	CcSEcCtD
Amantadine—DDC—Circadian rythm related genes—AVP—germ cell cancer	0.000463	0.00439	CbGpPWpGaD
Amantadine—Dyspnoea—Etoposide—germ cell cancer	0.000461	0.0024	CcSEcCtD
Amantadine—Somnolence—Etoposide—germ cell cancer	0.00046	0.00239	CcSEcCtD
Amantadine—Nausea—Bleomycin—germ cell cancer	0.000455	0.00237	CcSEcCtD
Amantadine—GRIN2B—Developmental Biology—KLF4—germ cell cancer	0.000455	0.00431	CbGpPWpGaD
Amantadine—Vomiting—Dactinomycin—germ cell cancer	0.000455	0.00236	CcSEcCtD
Amantadine—ABCB1—retina—germ cell cancer	0.000454	0.00184	CbGeAlD
Amantadine—Agranulocytosis—Methotrexate—germ cell cancer	0.000453	0.00236	CcSEcCtD
Amantadine—GRIN2B—Post NMDA receptor activation events—HRAS—germ cell cancer	0.000453	0.0043	CbGpPWpGaD
Amantadine—Rash—Dactinomycin—germ cell cancer	0.000451	0.00234	CcSEcCtD
Amantadine—Decreased appetite—Etoposide—germ cell cancer	0.00045	0.00234	CcSEcCtD
Amantadine—Diarrhoea—Ifosfamide—germ cell cancer	0.000448	0.00233	CcSEcCtD
Amantadine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000447	0.00232	CcSEcCtD
Amantadine—Body temperature increased—Cisplatin—germ cell cancer	0.000446	0.00232	CcSEcCtD
Amantadine—Fatigue—Etoposide—germ cell cancer	0.000446	0.00232	CcSEcCtD
Amantadine—Constipation—Etoposide—germ cell cancer	0.000442	0.0023	CcSEcCtD
Amantadine—DRD2—brain—germ cell cancer	0.000436	0.00176	CbGeAlD
Amantadine—Dizziness—Ifosfamide—germ cell cancer	0.000433	0.00225	CcSEcCtD
Amantadine—Urinary tract disorder—Methotrexate—germ cell cancer	0.000431	0.00224	CcSEcCtD
Amantadine—GRIN1—EPHB-mediated forward signaling—HRAS—germ cell cancer	0.000428	0.00406	CbGpPWpGaD
Amantadine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—germ cell cancer	0.000428	0.00406	CbGpPWpGaD
Amantadine—Urethral disorder—Methotrexate—germ cell cancer	0.000428	0.00222	CcSEcCtD
Amantadine—Feeling abnormal—Etoposide—germ cell cancer	0.000426	0.00222	CcSEcCtD
Amantadine—Nausea—Dactinomycin—germ cell cancer	0.000425	0.00221	CcSEcCtD
Amantadine—Visual impairment—Methotrexate—germ cell cancer	0.00042	0.00218	CcSEcCtD
Amantadine—GRIN2B—EPHB-mediated forward signaling—HRAS—germ cell cancer	0.000417	0.00396	CbGpPWpGaD
Amantadine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—germ cell cancer	0.000417	0.00396	CbGpPWpGaD
Amantadine—ABCB1—telencephalon—germ cell cancer	0.000417	0.00169	CbGeAlD
Amantadine—Vomiting—Ifosfamide—germ cell cancer	0.000417	0.00216	CcSEcCtD
Amantadine—Hypersensitivity—Cisplatin—germ cell cancer	0.000416	0.00216	CcSEcCtD
Amantadine—Rash—Ifosfamide—germ cell cancer	0.000413	0.00215	CcSEcCtD
Amantadine—Dermatitis—Ifosfamide—germ cell cancer	0.000413	0.00214	CcSEcCtD
Amantadine—Body temperature increased—Etoposide—germ cell cancer	0.000409	0.00213	CcSEcCtD
Amantadine—Eye disorder—Methotrexate—germ cell cancer	0.000408	0.00212	CcSEcCtD
Amantadine—Asthenia—Cisplatin—germ cell cancer	0.000405	0.00211	CcSEcCtD
Amantadine—Cardiac disorder—Methotrexate—germ cell cancer	0.000405	0.0021	CcSEcCtD
Amantadine—GRIN2C—Alzheimers Disease—TP53—germ cell cancer	0.000398	0.00377	CbGpPWpGaD
Amantadine—Angiopathy—Methotrexate—germ cell cancer	0.000396	0.00206	CcSEcCtD
Amantadine—ABCB1—decidua—germ cell cancer	0.000395	0.0016	CbGeAlD
Amantadine—Mediastinal disorder—Methotrexate—germ cell cancer	0.000393	0.00204	CcSEcCtD
Amantadine—Nausea—Ifosfamide—germ cell cancer	0.000389	0.00202	CcSEcCtD
Amantadine—Diarrhoea—Cisplatin—germ cell cancer	0.000386	0.00201	CcSEcCtD
Amantadine—Alopecia—Methotrexate—germ cell cancer	0.000385	0.002	CcSEcCtD
Amantadine—Mental disorder—Methotrexate—germ cell cancer	0.000382	0.00199	CcSEcCtD
Amantadine—Hypersensitivity—Etoposide—germ cell cancer	0.000381	0.00198	CcSEcCtD
Amantadine—Malnutrition—Methotrexate—germ cell cancer	0.00038	0.00197	CcSEcCtD
Amantadine—Asthenia—Etoposide—germ cell cancer	0.000371	0.00193	CcSEcCtD
Amantadine—GRIN2D—Alzheimers Disease—TP53—germ cell cancer	0.00037	0.00351	CbGpPWpGaD
Amantadine—Pruritus—Etoposide—germ cell cancer	0.000366	0.0019	CcSEcCtD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000365	0.00346	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.00036	0.00341	CbGpPWpGaD
Amantadine—Vomiting—Cisplatin—germ cell cancer	0.000359	0.00187	CcSEcCtD
Amantadine—Vision blurred—Methotrexate—germ cell cancer	0.000358	0.00186	CcSEcCtD
Amantadine—Rash—Cisplatin—germ cell cancer	0.000356	0.00185	CcSEcCtD
Amantadine—Dermatitis—Cisplatin—germ cell cancer	0.000356	0.00185	CcSEcCtD
Amantadine—Diarrhoea—Etoposide—germ cell cancer	0.000354	0.00184	CcSEcCtD
Amantadine—ABCB1—gonad—germ cell cancer	0.000348	0.00141	CbGeAlD
Amantadine—ABCB1—uterus—germ cell cancer	0.000346	0.0014	CbGeAlD
Amantadine—Dizziness—Etoposide—germ cell cancer	0.000342	0.00178	CcSEcCtD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.00034	0.00323	CbGpPWpGaD
Amantadine—Leukopenia—Methotrexate—germ cell cancer	0.00034	0.00177	CcSEcCtD
Amantadine—ABCB1—pituitary gland—germ cell cancer	0.00034	0.00137	CbGeAlD
Amantadine—Nausea—Cisplatin—germ cell cancer	0.000335	0.00174	CcSEcCtD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000335	0.00318	CbGpPWpGaD
Amantadine—Convulsion—Methotrexate—germ cell cancer	0.000329	0.00171	CcSEcCtD
Amantadine—Vomiting—Etoposide—germ cell cancer	0.000329	0.00171	CcSEcCtD
Amantadine—GRIN1—Developmental Biology—SOX2—germ cell cancer	0.000329	0.00312	CbGpPWpGaD
Amantadine—ABCB1—medulla oblongata—germ cell cancer	0.000328	0.00133	CbGeAlD
Amantadine—Rash—Etoposide—germ cell cancer	0.000326	0.0017	CcSEcCtD
Amantadine—Dermatitis—Etoposide—germ cell cancer	0.000326	0.00169	CcSEcCtD
Amantadine—Headache—Etoposide—germ cell cancer	0.000324	0.00168	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000321	0.00167	CcSEcCtD
Amantadine—GRIN2B—Developmental Biology—SOX2—germ cell cancer	0.00032	0.00304	CbGpPWpGaD
Amantadine—Confusional state—Methotrexate—germ cell cancer	0.000312	0.00162	CcSEcCtD
Amantadine—Anaphylactic shock—Methotrexate—germ cell cancer	0.00031	0.00161	CcSEcCtD
Amantadine—Nausea—Etoposide—germ cell cancer	0.000307	0.0016	CcSEcCtD
Amantadine—Nervous system disorder—Methotrexate—germ cell cancer	0.000304	0.00158	CcSEcCtD
Amantadine—GRIN2A—Alzheimers Disease—TP53—germ cell cancer	0.000304	0.00288	CbGpPWpGaD
Amantadine—ABCB1—adrenal gland—germ cell cancer	0.000303	0.00123	CbGeAlD
Amantadine—Skin disorder—Methotrexate—germ cell cancer	0.000301	0.00156	CcSEcCtD
Amantadine—ABCB1—midbrain—germ cell cancer	0.0003	0.00121	CbGeAlD
Amantadine—Hyperhidrosis—Methotrexate—germ cell cancer	0.0003	0.00156	CcSEcCtD
Amantadine—Anorexia—Methotrexate—germ cell cancer	0.000295	0.00154	CcSEcCtD
Amantadine—ABCB1—bone marrow—germ cell cancer	0.000294	0.00119	CbGeAlD
Amantadine—ABCB1—spinal cord—germ cell cancer	0.000292	0.00118	CbGeAlD
Amantadine—Hypotension—Methotrexate—germ cell cancer	0.00029	0.0015	CcSEcCtD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000284	0.00269	CbGpPWpGaD
Amantadine—ABCB1—female gonad—germ cell cancer	0.000283	0.00115	CbGeAlD
Amantadine—Insomnia—Methotrexate—germ cell cancer	0.00028	0.00146	CcSEcCtD
Amantadine—Paraesthesia—Methotrexate—germ cell cancer	0.000278	0.00145	CcSEcCtD
Amantadine—Dyspnoea—Methotrexate—germ cell cancer	0.000276	0.00144	CcSEcCtD
Amantadine—Somnolence—Methotrexate—germ cell cancer	0.000276	0.00143	CcSEcCtD
Amantadine—Dyspepsia—Methotrexate—germ cell cancer	0.000273	0.00142	CcSEcCtD
Amantadine—Decreased appetite—Methotrexate—germ cell cancer	0.000269	0.0014	CcSEcCtD
Amantadine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000268	0.00139	CcSEcCtD
Amantadine—Fatigue—Methotrexate—germ cell cancer	0.000267	0.00139	CcSEcCtD
Amantadine—GRIN1—Alzheimers Disease—TP53—germ cell cancer	0.000265	0.00251	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000264	0.00251	CbGpPWpGaD
Amantadine—ABCB1—endocrine gland—germ cell cancer	0.000263	0.00107	CbGeAlD
Amantadine—ABCB1—head—germ cell cancer	0.00026	0.00105	CbGeAlD
Amantadine—GRIN2B—Alzheimers Disease—TP53—germ cell cancer	0.000258	0.00245	CbGpPWpGaD
Amantadine—Feeling abnormal—Methotrexate—germ cell cancer	0.000255	0.00133	CcSEcCtD
Amantadine—ABCB1—testis—germ cell cancer	0.000251	0.00102	CbGeAlD
Amantadine—Body temperature increased—Methotrexate—germ cell cancer	0.000245	0.00127	CcSEcCtD
Amantadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	0.000244	0.00231	CbGpPWpGaD
Amantadine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	0.000241	0.00228	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—MYC—germ cell cancer	0.000234	0.00222	CbGpPWpGaD
Amantadine—ABCB1—cerebellum—germ cell cancer	0.000232	0.000938	CbGeAlD
Amantadine—Hypersensitivity—Methotrexate—germ cell cancer	0.000228	0.00119	CcSEcCtD
Amantadine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	0.000224	0.00212	CbGpPWpGaD
Amantadine—Asthenia—Methotrexate—germ cell cancer	0.000222	0.00116	CcSEcCtD
Amantadine—GRIN1—EPH-Ephrin signaling—HRAS—germ cell cancer	0.00022	0.00209	CbGpPWpGaD
Amantadine—Pruritus—Methotrexate—germ cell cancer	0.000219	0.00114	CcSEcCtD
Amantadine—GRIN2B—EPH-Ephrin signaling—HRAS—germ cell cancer	0.000215	0.00204	CbGpPWpGaD
Amantadine—Diarrhoea—Methotrexate—germ cell cancer	0.000212	0.0011	CcSEcCtD
Amantadine—Dizziness—Methotrexate—germ cell cancer	0.000205	0.00106	CcSEcCtD
Amantadine—Vomiting—Methotrexate—germ cell cancer	0.000197	0.00102	CcSEcCtD
Amantadine—Rash—Methotrexate—germ cell cancer	0.000195	0.00102	CcSEcCtD
Amantadine—Dermatitis—Methotrexate—germ cell cancer	0.000195	0.00101	CcSEcCtD
Amantadine—DDC—Metabolism—SLC2A3—germ cell cancer	0.000194	0.00184	CbGpPWpGaD
Amantadine—Headache—Methotrexate—germ cell cancer	0.000194	0.00101	CcSEcCtD
Amantadine—GRIN1—Spinal Cord Injury—TP53—germ cell cancer	0.000192	0.00182	CbGpPWpGaD
Amantadine—DDC—Metabolism—SLC22A3—germ cell cancer	0.000192	0.00182	CbGpPWpGaD
Amantadine—ABCB1—brain—germ cell cancer	0.000188	0.000762	CbGeAlD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000187	0.00177	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000185	0.00176	CbGpPWpGaD
Amantadine—Nausea—Methotrexate—germ cell cancer	0.000184	0.000957	CcSEcCtD
Amantadine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	0.000184	0.00174	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000183	0.00173	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—AVP—germ cell cancer	0.000183	0.00173	CbGpPWpGaD
Amantadine—ABCB1—lymph node—germ cell cancer	0.000182	0.000736	CbGeAlD
Amantadine—GRIN2C—Transmission across Chemical Synapses—HRAS—germ cell cancer	0.000181	0.00172	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000173	0.00164	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.00017	0.00161	CbGpPWpGaD
Amantadine—SLC22A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000168	0.0016	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—HRAS—germ cell cancer	0.000168	0.0016	CbGpPWpGaD
Amantadine—MAOB—Metabolism—SLC2A3—germ cell cancer	0.000164	0.00155	CbGpPWpGaD
Amantadine—MAOB—Metabolism—SLC22A3—germ cell cancer	0.000161	0.00153	CbGpPWpGaD
Amantadine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	0.00016	0.00152	CbGpPWpGaD
Amantadine—SLC22A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000157	0.00149	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—HRAS—germ cell cancer	0.000157	0.00149	CbGpPWpGaD
Amantadine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—germ cell cancer	0.000156	0.00148	CbGpPWpGaD
Amantadine—DDC—Metabolism—CRABP1—germ cell cancer	0.000156	0.00148	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000155	0.00147	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—HRAS—germ cell cancer	0.000153	0.00145	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—TP53—germ cell cancer	0.000146	0.00139	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—OXT—germ cell cancer	0.000142	0.00135	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—HRAS—germ cell cancer	0.000139	0.00131	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—HRAS—germ cell cancer	0.000138	0.00131	CbGpPWpGaD
Amantadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	0.000134	0.00127	CbGpPWpGaD
Amantadine—MAOB—Metabolism—CRABP1—germ cell cancer	0.000131	0.00125	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—HRAS—germ cell cancer	0.000129	0.00122	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.000128	0.00121	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—HRAS—germ cell cancer	0.000121	0.00114	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—HRAS—germ cell cancer	0.000117	0.00111	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—HRAS—germ cell cancer	0.000106	0.001	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000101	0.000961	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	9.98e-05	0.000946	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—AVP—germ cell cancer	9.75e-05	0.000925	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—HRAS—germ cell cancer	9.23e-05	0.000876	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—HRAS—germ cell cancer	9e-05	0.000853	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—SLC2A3—germ cell cancer	8.69e-05	0.000824	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—SLC22A3—germ cell cancer	8.56e-05	0.000811	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—AVP—germ cell cancer	8.55e-05	0.000811	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—HRAS—germ cell cancer	8.19e-05	0.000777	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SLC2A3—germ cell cancer	8.1e-05	0.000768	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—OXT—germ cell cancer	8.04e-05	0.000763	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—HRAS—germ cell cancer	7.99e-05	0.000757	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SLC22A3—germ cell cancer	7.98e-05	0.000756	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—AVP—germ cell cancer	7.97e-05	0.000756	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—OXT—germ cell cancer	7.3e-05	0.000692	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—CRABP1—germ cell cancer	6.98e-05	0.000661	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—CRABP1—germ cell cancer	6.5e-05	0.000617	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—HRAS—germ cell cancer	6.26e-05	0.000594	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—HRAS—germ cell cancer	5.85e-05	0.000554	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—HRAS—germ cell cancer	5.84e-05	0.000554	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TP53—germ cell cancer	5.76e-05	0.000546	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—HRAS—germ cell cancer	5.7e-05	0.00054	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—AVP—germ cell cancer	5.51e-05	0.000523	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—AVP—germ cell cancer	5e-05	0.000475	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—HRAS—germ cell cancer	4.8e-05	0.000455	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SLC2A3—germ cell cancer	4.75e-05	0.00045	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SLC22A3—germ cell cancer	4.67e-05	0.000443	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	4.67e-05	0.000443	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	4.52e-05	0.000429	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—HRAS—germ cell cancer	4.47e-05	0.000424	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—OXT—germ cell cancer	4.31e-05	0.000409	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—CRABP1—germ cell cancer	3.81e-05	0.000361	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	3.71e-05	0.000352	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FGF4—germ cell cancer	3.68e-05	0.000349	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—H2AFZ—germ cell cancer	3.29e-05	0.000312	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KITLG—germ cell cancer	3.02e-05	0.000287	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—AVP—germ cell cancer	2.96e-05	0.00028	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—FGFR3—germ cell cancer	2.25e-05	0.000213	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KIT—germ cell cancer	2.06e-05	0.000196	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HRAS—germ cell cancer	1.51e-05	0.000143	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MYC—germ cell cancer	1.14e-05	0.000108	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TP53—germ cell cancer	9.33e-06	8.84e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HRAS—germ cell cancer	8.92e-06	8.46e-05	CbGpPWpGaD
